HCA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
20.2B
+5.9%
19.1B
-2.1%
19.5B
+1.8%
19.2B
+3.0%
18.6B
Cost of Revenue
0
0
0
0
0
Gross Profit
20.2B
+5.9%
19.1B
-2.1%
19.5B
+1.8%
19.2B
+3.0%
18.6B
Operating Expenses
17.2B
+5.6%
16.2B
-0.3%
16.3B
+0.6%
16.2B
+3.6%
15.6B
R&D
0
0
0
0
0
SG&A
8.3B
+0.1%
8.3B
-0.9%
8.4B
-0.0%
8.4B
+2.8%
8.1B
Operating Income
3.1B
+7.1%
2.9B
-10.9%
3.2B
+8.4%
3.0B
-0.1%
3.0B
EBITDA
4.0B
+5.7%
3.8B
-8.1%
4.1B
+7.1%
3.9B
+0.6%
3.8B
Net Income
1.9B
+3.9%
1.9B
-14.1%
2.2B
+13.7%
1.9B
+0.6%
1.9B
EPS (Basic)
$7.70
+6.2%
$7.25
-12.5%
$8.29
+17.6%
$7.05
+2.0%
$6.91
EPS (Diluted)
$7.62
+6.6%
$7.15
-12.3%
$8.15
+17.1%
$6.96
+1.9%
$6.83
Shares (Diluted)
222.8M
-1.7%
226.7M
-1.6%
230.4M
-2.4%
236.2M
-2.4%
241.9M
HCA Healthcare (HCA) โ€” Financials